Medical News

RSS

Luminescent upconversion nanocrystals can detect cancer cells

Upconversion emission materials are ideal for bioimaging due to its effectiveness as contrast agents for the detection of cancer cells, more so when the background emission of non-cancerous tissues can be minimised. These materials could be used as biomarkers for luminescent labeling of cancerous cells. Opaque tissues can be turned into glassy, transparent substances by using these biomarkers which rely on near-infrared excitation.

14 Nov 2011

Leica Microsystems announces acquisition of Labindia's microscopy, histopathology business

Leica Microsystems, a world leading provider of microscopy systems and total histology solutions, today announced that it has acquired the microscopy and histopathology business of Labindia Instruments Pvt. Ltd., a leading solutions and service provider in India.

14 Nov 2011

Former soldier develops app to save lives of burns victims

A former soldier has developed an app which could save the lives of burns victims, both in combat and in hospitals around the world.

14 Nov 2011

Six-month results from BIOTRONIK's PRO-Kinetic Energy stent study presented at TCT 2011

BIOTRONIK AG announced that the six-month results of the ENERGY Registry were presented last week by Prof. Raimund Erbel at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference.

14 Nov 2011

BSP completes HyperQ technology clinical research study on CAD

BSP Biological Signal Processing Ltd. (BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company's HyperQ technology in diagnosing CAD.

14 Nov 2011

First study to look at alcohol consumption in adolescents and risk of breast disease

Adding to research linking alcohol to breast cancer risk, a new study from Washington University School of Medicine in St. Louis shows that adolescent girls with a family history of breast disease - either cancer or the benign lesions that can become cancer - have a higher risk of developing benign breast disease as young women than other girls. And unlike girls without a family history, this already-elevated risk rises with increasing alcohol consumption.

14 Nov 2011

Occupational chemical exposure raises for Parkinson's

A new research report contributes to the increasing evidence that repeated occupational exposure to certain chemical solvents raises the risk for Parkinson's disease. Researchers analyzed the occupational histories of twins in which one of the pair developed the neurodegenerative disorder, and assessed that twin's likelihood of exposure to six chemicals previously linked to Parkinson's.

14 Nov 2011

Mothers' behaviour during pregnancy can predict children at high risk of obesity

Researchers can predict which children are most likely to become obese by examining their mothers' behaviour around their birth, according to a recent University of Montreal study published in the Archives of Pediatric and Adolescent Medicine.

14 Nov 2011

Study uses fMRI to assess changes in brain after exercise intervention

Areas of the brain responsible for pain processing and cognitive performance changed in fibromyalgia patients who exercised following a medication holiday, say researchers from Georgetown University Medical Center. They say the changes indicate brain functioning is more streamlined after an exercise intervention because less of the brain-s resources is devoted to processing bothersome fibromyalgia perceptions such as pain.

14 Nov 2011

Scientists discover molecular basis for tamoxifen resistance and potential way to defeat it

In the last three decades, thousands of women with breast cancer have taken the drug tamoxifen, only to discover that the therapy doesn't work, either because their tumors do not respond to the treatment at all, or because they develop resistance to it over time. Now researchers at the University of California, San Francisco (UCSF) have discovered the molecular basis for tamoxifen resistance and found a potential way to defeat it.

14 Nov 2011

Scientists create new phenotypic cancer drug screening platform

Researchers have created a new phenotypic screening platform that better predicts success of drugs developed to prevent blood vessel tumor growth when moving out of the lab and onto actual tumors.

14 Nov 2011

Racial disparities in long-term survival among pediatric heart transplant patients

White heart transplant patients under the age of 18 are more than twice as likely to be alive a decade after surgery as their African-American counterparts, new Johns Hopkins research suggests.

14 Nov 2011

New-onset AF, severe sepsis may increase risk of stroke and mortality in hospital settings

A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.

14 Nov 2011

Scientists identify factors that lead to concomitant tumor resistance

Scientists are another step closer to understanding what drives tumor metastasis, as laboratory models suggest there are factors inside tumors that can slow their own growth.

14 Nov 2011

Genzyme's alemtuzumab Phase lll trial on MS meets co-primary endpoints

Genzyme, a Sanofi company, reports today that the Phase lll CARE-MS ll trial met both of its co-primary endpoints. Relapse rate and sustained accumulation (worsening) of disability (SAD) were significantly reduced in multiple sclerosis patients receiving alemtuzumab as compared with Rebif.

14 Nov 2011

Exposure to TCE may increase risk of Parkinson’s

A novel study in twins found that exposure to trichloroethylene (TCE)—a hazardous organic contaminant found in soil, groundwater, and air—is significantly associated with increased risk of Parkinson’s disease.

14 Nov 2011

Next-generation drugs may prevent skin lesions in BRAF mutation-positive melanoma

Findings from preclinical studies in a skin cancer model showed that next-generation BRAF inhibitors used alone, or first-generation BRAF inhibitors used in combination with an epidermal growth factor receptor inhibitor, may have the potential to prevent drug-induced skin lesions in BRAF mutation-positive patients treated for melanoma.

14 Nov 2011

Link between sugar-sweetened beverages and increased cardiovascular risk in women

Drinking two or more sugar-sweetened beverages a day may expand a woman's waistline and increase her risk of heart disease and diabetes, according to research presented at the American Heart Association's Scientific Sessions 2011.

14 Nov 2011

Hypertrophic cardiomyopathy is consistent with survival to normal life expectancy

Hypertrophic cardiomyopathy (HCM) is consistent with survival to normal life expectancy, including particularly advanced age into the tenth decade of life, with demise ultimately largely unrelated to this disease, according to a study being presented Nov. 13 at the American Heart Association (AHA) scientific sessions in Orlando, Fla.

14 Nov 2011

ZIOPHARM announces darinaparsin preclinical data on prostate cancer

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.

14 Nov 2011

Medical News

Luminescent upconversion nanocrystals can detect cancer cells

Leica Microsystems announces acquisition of Labindia's microscopy, histopathology business

Former soldier develops app to save lives of burns victims

Six-month results from BIOTRONIK's PRO-Kinetic Energy stent study presented at TCT 2011

BSP completes HyperQ technology clinical research study on CAD

First study to look at alcohol consumption in adolescents and risk of breast disease

Occupational chemical exposure raises for Parkinson's

Mothers' behaviour during pregnancy can predict children at high risk of obesity

Study uses fMRI to assess changes in brain after exercise intervention

Scientists discover molecular basis for tamoxifen resistance and potential way to defeat it

Scientists create new phenotypic cancer drug screening platform

Racial disparities in long-term survival among pediatric heart transplant patients

New-onset AF, severe sepsis may increase risk of stroke and mortality in hospital settings

Scientists identify factors that lead to concomitant tumor resistance

Genzyme's alemtuzumab Phase lll trial on MS meets co-primary endpoints

Exposure to TCE may increase risk of Parkinson’s

Next-generation drugs may prevent skin lesions in BRAF mutation-positive melanoma

Link between sugar-sweetened beverages and increased cardiovascular risk in women

Hypertrophic cardiomyopathy is consistent with survival to normal life expectancy

ZIOPHARM announces darinaparsin preclinical data on prostate cancer

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News